Page 1 of Clinical Trials for Blast Crisis, 383 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Accelerated Phase or Blast Phase (Blast Crisis)
Last Updated: May 1, 2012
Condition(s): Leukemia, Myeloid, Chronic
2
Completed
Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)
Last Updated: May 16, 2012
Condition(s): Myeloid Leukemia, Chronic; Myeloid Leukemia, Chronic, Accelerated-Phase; Blast Phase; Myeloid Leukemia, Chronic, Chronic-Phase
3
Active, not recruiting
A Phase 1/2 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia
Last Updated: January 20, 2011
Condition(s): Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Blastic Phase Chronic Myelogenous Leukemia; CML
4
Active, not recruiting
An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Patients (Male or Female ≥18 Years) With Ph + CML in Blast Crisis
Last Updated: October 19, 2011
Condition(s): Philadelphia Positive Chronic Myeloid Leukemia in Myeloid Blast Crisis
5
No longer available
Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant
Last Updated: July 12, 2011
Condition(s): Chronic Myelogenous Leukemia
6
Completed
Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate
Last Updated: August 3, 2010
Condition(s): Chronic Myeloid Leukemia; Blast Crisis
7
Completed
Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive
Last Updated: October 4, 2011
Condition(s): Leukemia, Lymphocytic, Acute; Philadelphia Chromosome; Blast Crisis; Leukemia, Myeloid, Chronic
8
Active, not recruiting
STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis
Last Updated: June 4, 2011
Condition(s): Leukemia
9
Completed
Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
Last Updated: October 14, 2011
Condition(s): Leukemia
10
Completed
Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia
Last Updated: June 4, 2011
Condition(s): Leukemia
11
Approved for marketing
Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Last Updated: March 14, 2011
Condition(s): Chronic Myeloid Leukemia
12
Completed
3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia
Last Updated: August 5, 2011
Condition(s): Chronic Myeloproliferative Disorders; Leukemia
13
Active, not recruiting
A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Last Updated: April 23, 2012
Condition(s): Chronic Myeloid Leukemia
14
Completed
Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial
Last Updated: September 20, 2011
Condition(s): Chronic Myelogenous Leukemia
15
Active, not recruiting
A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
Last Updated: April 23, 2012
Condition(s): Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive); Hypereosinophilic Syndrome; Systemic Mastocytosis
16
Completed
Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia
Last Updated: March 29, 2012
Condition(s): Leukemia; Myelodysplastic Syndromes
17
Completed
PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome
Last Updated: July 23, 2008
Condition(s): Leukemia; Myelodysplastic Syndromes
18
Completed
BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia
Last Updated: April 13, 2011
Condition(s): Leukemia, Myeloid, Chronic-phase; Leukemia, Lymphoblastic, Acute, Philadelphia-positive
19
Completed
Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Last Updated: April 7, 2011
Condition(s): Chronic Myeloid Leukemia; Leukemia, Lymphoblastic, Acute, Philadelphia-positive
20
Active, not recruiting
An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Last Updated: April 16, 2012
Condition(s): Leukemia, Myeloid, Chronic

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Blast+Crisis

Page 1 of Clinical Trials for Blast Crisis, 383 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About